Although duodenogastric reflux is a physiological event, excessive reflux may be a pathogenetic factor in several diseases ofthe foregut, including cancer. Long term profound duodenogastric reflux produces pancreatic and gastric tumours in rats. The trophic effect of surgically induced duodenogastric reflux on the pancreas was investigated and the mechanisms involved were examined. Rats with profound reflux from a split gastroenterostomy were compared with sham operated and unoperated controls after two and six weeks. In the six week experiment, one reflux and one sham group were given the cholecystokinin (CCK) receptor antagonist devazepide (25 nmollkg/h). Duodenogastric reflux caused a significant increase in pancreatic weight, DNA, and plasma CCK and gastrin concentrations at both two and six weeks. Devazepide substantially reduced the pancreatic weight increase after six weeks but did not abolish it completely. CCK and gastrin were not affected by devazepide. These results suggest that CCK is largely responsible for the pancreatic growth induced by reflux but another factor may also be involved. The trophic effect of duodenogastric reflux may contribute to the increased incidence of pancreatic cancer reported after gastric surgery. (Gut 1995; 36: 137-141) Keywords: duodenogastric reflux, pancreatic growth. model was used to investigate the short term effects of pronounced duodenogastric reflux on pancreatic growth in the rat, and to evaluate the role of CCK in this process.
The trophic effect of surgically induced duodenogastric reflux on the pancreas was investigated and the mechanisms involved were examined. Rats with profound reflux from a split gastroenterostomy were compared with sham operated and unoperated controls after two and six weeks. In the six week experiment, one reflux and one sham group were given the cholecystokinin (CCK) receptor antagonist devazepide (25 nmollkg/h). Duodenogastric reflux caused a significant increase in pancreatic weight, DNA, and plasma CCK and gastrin concentrations at both two and six weeks. Devazepide substantially reduced the pancreatic weight increase after six weeks but did not abolish it completely. CCK and gastrin were not affected by devazepide. These results suggest that CCK is largely responsible for the pancreatic growth induced by reflux but another factor may also be involved. The trophic effect of duodenogastric reflux may contribute to the increased incidence of pancreatic cancer reported after gastric surgery. (Gut 1995; 36: 137-141) Keywords: duodenogastric reflux, pancreatic growth. model was used to investigate the short term effects of pronounced duodenogastric reflux on pancreatic growth in the rat, and to evaluate the role of CCK in this process.
Methods
Male Wistar rats weighing 175-200 g (Sasco Inc, Omaha, Nebraska, USA), were used in the study. They were housed individually and fed standard pelleted rat chow with free access to water.
DESIGN OF THE STUDY
Experiment I To investigate possible growth effects of duodenogastric reflux on the pancreas, a group of rats with a split gastrojejunostomy (n= 10) were compared with sham operated rats (n=8) and unoperated controls (n=8), two weeks after surgery.
Experiment II
The effects of duodenogastric reflux were studied six weeks after surgery. Seventeen animals had a split gastrojejunostomy performed and eight of these also received the specific CCK receptor antagonist devazepide (also called MK329, Merck Sharp & Dohme).20 These were compared with sham operated rats with and without devazepide (n=6 and n=7, respectively) and unoperated controls (n= 5). A split gastrojejunostomy (Fig 1) was performed through an upper midline incision under general anaesthesia (ketamine hydrochloride 100 mg/ml:xylazine 100 mg/ml, 10:1, 0.1 ml/100 mg body weight). The proximal jejunum was divided approximately 2 cm distal to the ligament of Treitz and the afferent loop was anastomosed to the greater curvature of the stomach 2-3 mm distal to the squamocolumnar junction using one layer of interrupted 7-0 Prolene sutures. The efferent jejunal loop was anastomosed to the stomach 10 mm distal to the afferent loop with the same technique. A sham operation was performed by transecting the proximal jejunum at the same point, anastomosing the bowel ends, and attaching the anastomosis to the stomach serosa. The surgery was performed after overnight fasting and the animals were deprived of water for 24 hours and of food for 48 hours after the procedure.
The CCK receptor antagonist devazepide was administered continuously (25 Ci/mmol, Amersham Corp, Arlington, IL; 1 mCi/kg), and killed one hour after the injection. They were anaesthetised in the same manner as for surgery (see above), the thorax was opened, and blood was collected from the right ventricle of the heart. The animals were thereby killed by exsanguination. The pancreas was excised; carefully dissected free from con- The pancreatic wet weight was significantly increased in the duodenogastric reflux animals after two weeks and was further increased after six weeks compared with sham (Fig 2) .
weeks
Devazepide reduced the pancreatic weight increase significantly (p<005) after six weeks in the duodenogastric reflux group to a level that was not significantly different from that of the sham operated rats (Fig 2) . There was no difference in pancreatic wet weight between the sham operated animals and the unoperated controls at either two or six weeks. No significant difference was found in duodenal or jejunal mucosal weights between the duodenogastric reflux group and the sham or control groups at either time point (data not shown).
PANCREATIC DNA AND PROTEIN CONTENT After six weeks, there was a significant increase in pancreatic DNA (mg/100 g body weight) in the duodenogastric reflux animals compared with the sham operated animals (p<005) (Table) . The difference in pancreatic DNA after two weeks did not reach statistical significance. The total pancreatic protein content was not significantly changed after either two or six weeks (data not shown).
3H-THYMIDINE UPTAKE
No difference in 3H-thymidine uptake in pancreatic tissue or small bowel mucosa was observed between the groups at either two or six weeks (data not shown).
CCK AND GASTRIN CONCENTRATIONS
After both two and six weeks of duodenogastric reflux, plasma CCK and gastrin con- (Fig 3) . Deva plasma levels of eithei CCK content in the jej cantly decreased after denogastric reflux g controls (Fig 4) 16 Their finding creased approximately could be either a long term effect not seen izepide did not affect the within the first six weeks or due to differences r of these peptides. The in the surgical techniques used. In our study, junal mucosa was signifi-duodenogastric reflux induced pancreatic two weeks in the duo-growth, mainly hyperplasia, and a threefold group compared with increase in plasma CCK concentrations. The there was no significant increased pancreatic DNA synthesis, however, (data not shown). CCK must occur within the first two weeks since the )sa was not changed by 3H-thymidine uptake was unchanged at both ime point studied.
time points, despite an increase in DNA content. This is similar to our experience with the pancreaticobiliary diversion model. 37 In a previous study, it was suggested that the x is a normal physio-source of increased plasma CCK was the !5 which can become hyperplastic duodenum and that the main after gastric surgery in mechanism was stasis of food within the duofunction is lost. Exces-denal loop.1631 In the short term, however, eflux can give rise to a we did not see duodenal hyperplasia. h upper abdominal dis-Furthermore, the decreased CCK content in en implicated as a major the jejunal mucosa at two weeks (and a similar .sis of a variety of benign but not significant tendency found after six t diseases, especially in weeks), together with the unchanged duodenal the stomach.27-30 Long mucosal weight and mucosal CCK content nogastric reflux in rats, caused by the split gastrojejunostomy in our rojejunostomy, has been study, suggests an increased turnover of the nomatous nodules in the peptide in the efferent jejunal loop. A possible rs found increased CCK explanation for this effect of reflux on CCK is :ions associated with the an inactivation of trypsin when passing y after four weeks.31 As through the acid milieu in the stomach and, s in man have suggested thus, inhibition of the CCK releasing feedback ry, especially Billroth II mechanism in the efferent jejunal loop. a risk factor for pan-Furthermore, it is known that gastric surgery, ther study of the mecha-with bypass of the pylorus, usually induces surgery, and associated rapid gastric emptying. Since CCK slows may induce pancreatic gastric emptying and intestinal transit,38 the st.
increased plasma CCK could represent an ias been seen with bowel adaptive response. Studies in humans with with cholecystectomy in previous gastric surgery have shown increased been suggested as the postprandial levels of CCK,39 40 and we have ponsible but the mecha-found increased CCK concentrations posts increased is not estab-prandially in patients with primary duoase in the plasma CCK denogastric reflux.41 s seen after pancreaticoAs the CCK receptor antagonist did not the upper small intes-completely abolish the pancreatic growth of CCK is normally response to the procedure, it is probable that g amounts of the pan-some other factor (or factors) in addition to in in the upper small CCK are involved. This could also reflect an pancreaticobiliary diver-inadequate dose of devazepide but the dose 11 small intestine void of used was the same as has previously been mechanism is compro-shown to antagonise effects on the pancreas liary diversion induces of supra-physiological doses of exogenous l5 [7] [8] [9] and, in long term CCK.21 42 A similar dose of devazepide was atic tumours even in the also able to reduce the effect on pancreatic 5.36 We have previously growth by pancreaticobiliary diversion but not significantly affect the size of the normal pancreas.9 In the present study, we also found significantly increased plasma gastrin concentrations in the duodenogastric reflux rats, an increase which could be expected after alkalinisation of the stomach. This is in agreement with Taylor's observations.31 The effect of gastrin on pancreatic growth is controversial.243 In some studies, however, it has been shown to have a weak trophic effect on the pancreas.2 44 It is thus possible that gastrin, in combination with an increase in CCK concentration, could contribute to the growth effects observed in this model.
Pronounced duodenogastric reflux in rats results in pancreatic hyperplasia, due at least partly to increased plasma CCK concentrations. The mechanism by which CCK is increased, however, still has to be elucidated.
CCK does not seem to be the sole responsiblet growth factor in this experimental model. Among other possible candidates is gastrin, which, in some animal studies, has been shown to have trophic effects on the pancreas.2 44 The trophic mechanism is of importance as it may contribute to the increased incidence of pancreatic cancer reported after gastric surgery.
pancreatic growth in rats. 
Profound duodenogastric reflux causes

